Ticker

Key Highlights Precision molds received for manufacturing of new optimized accommodating intraocular lenses

Calgary, Alberta – TheNewswire - April 29, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a private placement (the “ Offering ”) of up to 2,800,000 units of the Corporation (“ Units ”) at a price of $0.55 per Unit for gross proceeds of up to $1,540,000. There will be no minimum subscription level for the Offering.…

Key Highlights   Vision performance: Clinical outcomes exceed expectations, with all patients experiencing continuing vision improvements

Key Highlights   No material change:  There is no material change in the business affairs of Ocumetics.

Key Highlights   Early First-in-Human clinical results have drawn the attention of industry leaders and several of the largest vision care technology companies in the world.